11-36500710-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004620.4(TRAF6):​c.296+510A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.767 in 151,934 control chromosomes in the GnomAD database, including 45,894 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.77 ( 45894 hom., cov: 30)

Consequence

TRAF6
NM_004620.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.449

Publications

13 publications found
Variant links:
Genes affected
TRAF6 (HGNC:12036): (TNF receptor associated factor 6) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain and mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. The protein encoded by this gene is a key molecule in antiviral innate and antigen-specific immune responses. [provided by RefSeq, Nov 2021]
TRAF6 Gene-Disease associations (from GenCC):
  • autosomal dominant hypohidrotic ectodermal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.852 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004620.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF6
NM_004620.4
MANE Select
c.296+510A>G
intron
N/ANP_004611.1Q9Y4K3
TRAF6
NM_145803.3
c.296+510A>G
intron
N/ANP_665802.1Q9Y4K3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF6
ENST00000526995.6
TSL:1 MANE Select
c.296+510A>G
intron
N/AENSP00000433623.1Q9Y4K3
TRAF6
ENST00000348124.5
TSL:1
c.296+510A>G
intron
N/AENSP00000337853.5Q9Y4K3
TRAF6
ENST00000876418.1
c.296+510A>G
intron
N/AENSP00000546477.1

Frequencies

GnomAD3 genomes
AF:
0.767
AC:
116468
AN:
151816
Hom.:
45885
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.572
Gnomad AMI
AF:
0.926
Gnomad AMR
AF:
0.857
Gnomad ASJ
AF:
0.811
Gnomad EAS
AF:
0.873
Gnomad SAS
AF:
0.779
Gnomad FIN
AF:
0.824
Gnomad MID
AF:
0.825
Gnomad NFE
AF:
0.843
Gnomad OTH
AF:
0.782
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.767
AC:
116516
AN:
151934
Hom.:
45894
Cov.:
30
AF XY:
0.770
AC XY:
57222
AN XY:
74268
show subpopulations
African (AFR)
AF:
0.572
AC:
23661
AN:
41394
American (AMR)
AF:
0.857
AC:
13075
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.811
AC:
2815
AN:
3470
East Asian (EAS)
AF:
0.873
AC:
4488
AN:
5138
South Asian (SAS)
AF:
0.779
AC:
3749
AN:
4814
European-Finnish (FIN)
AF:
0.824
AC:
8713
AN:
10574
Middle Eastern (MID)
AF:
0.822
AC:
240
AN:
292
European-Non Finnish (NFE)
AF:
0.843
AC:
57282
AN:
67978
Other (OTH)
AF:
0.784
AC:
1652
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1259
2519
3778
5038
6297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
852
1704
2556
3408
4260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.809
Hom.:
14472
Bravo
AF:
0.762
Asia WGS
AF:
0.809
AC:
2816
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
6.4
DANN
Benign
0.86
PhyloP100
0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030445; hg19: chr11-36522260; API